6 completed, 1 recruiting, 1 terminated. 8 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 6, Recruiting 1, Terminated 1 |
Follow Recurrent Childhood Soft Tissue Sarcoma: new trials by email Literature Review of Recurrent Childhood Soft Tissue Sarcoma trials Research Report on Recurrent Childhood Soft Tissue Sarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling Functional Precision Medicine - Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia | Phase 1 | Recruiting | Florida International University | 65 | 2023-02-22 | 2026-08-26 |
| Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease Bevacizumab, Cetuximab, Laboratory Biomarker Analysis - Advanced Malignant Neoplasm, Castleman Disease | Phase 1 | Terminated | M.D. Anderson Cancer Center | 116 | 2012-10-16 | 2026-11-05 |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment pazopanib hydrochloride, pharmacological study - Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 55 | 2009-06-01 | 2013-09-30 |
| Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Cixutumumab, Doxorubicin Hydrochloride, Laboratory Biomarker Analysis - Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2008-06-01 | 2016-05-17 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas irinotecan hydrochloride, oxaliplatin - Childhood Burkitt Lymphoma, Childhood Central Nervous System Germ Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 24 | 2005-03-01 | 2013-06-05 |
| Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors tanespimycin, pharmacological study, laboratory biomarker analysis - Childhood Chronic Myelogenous Leukemia, Childhood Desmoplastic Small Round Cell Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 70 | 2004-09-01 | 2013-06-04 |
| Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid Tumors erlotinib hydrochloride, temozolomide, pharmacological study - Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Brain Tumor | Phase 1 | Completed | National Cancer Institute (NCI) | 95 | 2004-02-01 | 2013-06-05 |
| Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas alvocidib, pharmacological study - Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 2001-04-01 | 2013-07-02 |
Familial ependymoma (4) · Neuroblastoma (4) · Osteosarcoma (4) · Astrocytoma (3) · Dendritic Cell Sarcoma, Interdigitating (3) · Medulloblastoma (3) · Neuroectodermal Tumors, Primitive, Peripheral (3) · Optic Nerve Glioma (3) · Recurrence (3) · Burkitt Lymphoma (2) · Desmoplastic Small Round Cell Tumor (2) · Neoplasms (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Sarcoma (2) · Wilms Tumor (2)
Neoplasms by Histologic Type (8) · Neoplasms, Nerve Tissue (7) · Neoplasms (6) · Neoplasms, Connective and Soft Tissue (6) · Neoplasms, Germ Cell and Embryonal (6) · Neoplasms, Glandular and Epithelial (6) · Neuroectodermal Tumors (6) · Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms, Connective Tissue (5) · Neoplasms, Neuroepithelial (5) · Nervous System Diseases (5)
Bevacizumab (1) · Cetuximab (1) · Disulfides (1) · Doxorubicin (1) · Erlotinib Hydrochloride (1) · Immunoglobulin G (1) · Irinotecan (1) · Oxaliplatin (1) · Sirolimus (1) · Temozolomide (1) · Valproic Acid (1) · alvocidib (1) · cixutumumab (1) · pazopanib (1) · tanespimycin (1)
National Cancer Institute (NCI) (6) · Florida International University (1) · M.D. Anderson Cancer Center (1)
United States (8)
Diana Azzam (1) · James Whitlock (1) · Julia Glade-Bender (1) · Lisa McGregor (1) · Maggie Fader (1) · Rashmi Chugh (1) · Regina Jakacki (1) · Sarina A Piha-Paul (1) · Tanya Trippett (1)
PMID 23857966, PMID 25858498, PMID 26933802, PMID 37311055, PMID 41389341
U01CA097452 (4), N01CM00071 (1), P30CA014599 (1), U01CA069856 (1), U54MD012393 (1)